Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Growth 2024-2030

Global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Market Growth 2024-2030

Lutetium-177 is a radioactive isotope of lutetium, a rare earth metal, with a half-life of about 6.7 days. Lutetium-177 is a beta emitter, meaning that as it decays it releases beta radiation—high-energy electrons the unstable atom can no longer contain. Beta radiation is particularly useful for cancer treatment because of how effectively attenuated it is by biological soft tissues. By applying radioisotopes like Lu-177 to the right area, the beta radiation released can destroy tumors while causing minimal damage to the surrounding healthy tissue. Lu-177 also emits gamma radiation.

Lutetium-177 can be produced as carrier added (ca) and no carrier added (nca) from enriched 177Lu or 176Yb. The later requires separation of Lu from the Yb target following irradiation. Non-carrier added Lutetium-177 (n.c.a. Lu-177) is emerging as a radioisotope of choice for targeted radionuclide therapy.

The global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Non-carrier Added Lutetium-177 (n.c.a. Lu-177) Industry Forecast” looks at past sales and reviews total world Non-carrier Added Lutetium-177 (n.c.a. Lu-177) sales in 2023, providing a comprehensive analysis by region and market sector of projected Non-carrier Added Lutetium-177 (n.c.a. Lu-177) sales for 2024 through 2030. With Non-carrier Added Lutetium-177 (n.c.a. Lu-177) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-carrier Added Lutetium-177 (n.c.a. Lu-177) industry.

This Insight Report provides a comprehensive analysis of the global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-carrier Added Lutetium-177 (n.c.a. Lu-177) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-carrier Added Lutetium-177 (n.c.a. Lu-177) and breaks down the forecast by Specification, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-carrier Added Lutetium-177 (n.c.a. Lu-177).

United States market for Non-carrier Added Lutetium-177 (n.c.a. Lu-177) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Non-carrier Added Lutetium-177 (n.c.a. Lu-177) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Non-carrier Added Lutetium-177 (n.c.a. Lu-177) is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Non-carrier Added Lutetium-177 (n.c.a. Lu-177) players cover SHINE Technologies, NRG, Eckert & Ziegler, ITM, Isotopia Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-carrier Added Lutetium-177 (n.c.a. Lu-177) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Specification:
50 GBq/mL
200 GBq/mL
Others

Segmentation by Application:
Targeted Molecular Radiotherapy
Medical Imaging

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
SHINE Technologies
NRG
Eckert & Ziegler
ITM
Isotopia Ltd
ANSTO
Monrol
China Tongfu Stock

Key Questions Addressed in this Report

What is the 10-year outlook for the global Non-carrier Added Lutetium-177 (n.c.a. Lu-177) market?

What factors are driving Non-carrier Added Lutetium-177 (n.c.a. Lu-177) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Non-carrier Added Lutetium-177 (n.c.a. Lu-177) market opportunities vary by end market size?

How does Non-carrier Added Lutetium-177 (n.c.a. Lu-177) break out by Specification, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.